Does TACROLIMUS Cause Forced expiratory volume decreased? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Forced expiratory volume decreased have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.0% of all adverse event reports for TACROLIMUS.
21
Reports of Forced expiratory volume decreased with TACROLIMUS
0.0%
of all TACROLIMUS reports
2
Deaths
4
Hospitalizations
How Dangerous Is Forced expiratory volume decreased From TACROLIMUS?
Of the 21 reports, 2 (9.5%) resulted in death, 4 (19.0%) required hospitalization.
Is Forced expiratory volume decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Forced expiratory volume decreased?
OMALIZUMAB (1,497)
ALBUTEROL (344)
PREDNISONE (335)
MONTELUKAST (274)
TIOTROPIUM (236)
MEPOLIZUMAB (209)
METFORMIN (183)
BUDESONIDE\FORMOTEROL (171)
BUDESONIDE (150)
LEVOFLOXACIN (138)
Which TACROLIMUS Alternatives Have Lower Forced expiratory volume decreased Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB